Post-liver transplant Crohn's disease graft tolerance but not self-tolerance?

Digestive Diseases and Sciences

Volumn 47, Issue 3, 2002, Pages 522-527

  Ramji, Alnoor ^a   Owen, David A ^a   Erb, Siegfried R ^a   Scudamore, Charles H ^b   Yoshida, Eric M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Colitis; Crohn's disease; Liver; Transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOGRAFT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHRONIC HEPATITIS; CROHN DISEASE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; LIVER TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS;

COLON; CROHN DISEASE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; ILEUM; IMMUNE TOLERANCE; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0036121817     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017951632444     Document Type: Article

References (29)

1. The immunologic basis of inflammatory bowel disease
2. Aetiology and pathogenesis of chronic inflammatory bowel disease
3. Primary sclerosing cholangitis
4. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation
5. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients
6. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease
7. Development of ulcerative colitis under the immunosuppressive effect of cyclosporine
8. Onset of ulcerative colitis during immunosuppressive therapy for liver transplantation
9. Medical therapies for inflammatory bowel disease
10. A placebo controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease
11. Reliability and predictive value of the NIDDK liver transplant database nomenclature and grading system for cellular rejection of liver allografts
12. Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodeficiency syndrome
13. Terminal ileitis associated with cytomegalovirus and the acquired immunodeficiency syndrome
14. Cyclosporine therapy for inflammatory bowel disease
15. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis
16. Treatment of Crohn's disease at the turn of the century
17. Clinical course and management of inflammatory bowel disease after liver transplantation
18. Cyclosporine treatment of inflammatory bowel disease
19. Low-dose cyclosporine for the treatment of Crohn's disease
20. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small-bowel and fistulizing Crohn's disease
21. Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506)
22. Oral tracrolimus long-term therapy in patients with Crohn's disease and steroid resistance
23. Cytokines and their natural regulation in inflammatory bowel disease: A review
24. Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: Evaluation of in-vitro model
25. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease
26. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease
27. Role of NFκB in immune and inflammatory responses in the gut
28. Cytokine-based therapies in inflammatory bowel disease
29. Inflammatory bowel disease